Results 121 to 130 of about 11,186 (206)

Efficacy of dihydroartemisinin-piperaquine to prevent malaria and complication-related malaria during pregnancy compared to sulfadoxine-pyrimethamine: a systematic review, meta-analysis, and meta-regression. [PDF]

Epidemiol Infect
Simanjuntak AMT, Wijayanto FPS, Nugraha RTH, Prathama FH, Ramadhan RN, Mulya Perdana T, Haposan JH, Nugrahani AD, Hartantri Y, Maulana S.   +9 more
europepmc   +1 more source

[Expression of Concern] <i>In vitro</i> and <i>in vivo</i> inhibition of tumor cell viability by combined dihydroartemisinin and doxorubicin treatment, and the underlying mechanism. [PDF]

Oncol Lett
Tai X, Cai XB, Zhang Z, Wei R.
europepmc   +1 more source

In vitro activity of dihydroartemisinin against clinical isolates of Plasmodium falciparum in Yaounde, Cameroon

, 1999
The in vitro activities of dihydroartemisinin (the biologically active metabolite of artemisinin derivatives), chloroquine, monodesethylamodiaquine (the biologically active metabolite of amodiaquine), quinine, mefloquine, halofantrine, and pyrimethamine ...
Basco, L., Ringwald, Pascal, Bickii, Jean   +2 more
core  

Structural and Functional Impact of the G340S Mutation in Plasmodium falciparum Ferredoxin NADP⁺ Reductase: In silico Analysis and Molecular Docking. [PDF]

Gates Open Res
Kiboi D, Muriithi B.
europepmc   +1 more source

Dihydroartemisinin for the treatment of polycystic ovary syndrome: study protocol for a multi-centre placebo-controlled randomised clinical trial. [PDF]

BMJ Open
Mu L, Shen Y, Wang G, Liu C, Yang H, Li W, Mol BW, Li X, Dong X, Jiang J.   +9 more
europepmc   +1 more source

Effects of malaria intermittent preventive treatment with dihydroartemisinin-piperaquine on antiretroviral drug concentrations in African pregnant women living with HIV. [PDF]

Antimicrob Agents Chemother
Stöger L, Mischlinger J, Nhampossa T, Mombo-Ngoma G, Esen M, Tchouatieu A-M, Brunet M, Mendes A, Dimessa Mbadinga LB, Gamberini S, Ndzebe Ndoumba W, Figueroa-Romero A, Lell B, Lagler H, Zoleko-Manego R, El Gaaloul M, Méndez S, Botella N, Sanz S, Piqueras M, Sevene E, Saúte F, Wicha SG, Soy D, Menéndez C, Ramharter M, González R, MAMAH Study Group.   +27 more
europepmc   +1 more source

Maternal, Fetal, and Neonatal Outcomes of Additional Dihydroartemisinin-Piperaquine to Trimethoprim-Sulfamethoxazole in Intermittent Preventive Treatment for Malaria in HIV-Positive Pregnancies: A Systematic Review and Meta-Analysis. [PDF]

Ther Clin Risk Manag
Yunivita V, Maharani AJ, Bernadus CA, Sinaga EIJ, Simanjuntak ER.   +4 more
europepmc   +1 more source

Ex vivo susceptibility to dihydroartemisinin in Plasmodium falciparum patient isolates from Eastern Rwanda, 2025. [PDF]

Malar J
Oliveira R, Musabyimana JP, Kabalisa E, Gashema P, Nshimiyimana F, Buregeya JD, Uwumutima I, Hitimana E, Habarugira F, Ngarambe C, Muvunyi CM, Ndoli Minega J, Mockenhaupt FP, van Loon W.   +13 more
europepmc   +1 more source

Integrating UHPLC-Q-TOF-MS, Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulations to Reveal the Potential Mechanisms of Yiguanjian Decoction in Treating Liver Cancer. [PDF]

Chem Biodivers
Wen X, Zhang X, Fang W, Liu H, Cai F.
europepmc   +1 more source

The Impact of <i>pfmdr1</i> Gene Copy Number on the Efficacy of Dihydroartemisinin-Piperaquine in Treating Malaria in West Sumba and Kupang Districts, East Nusa Tenggara, Indonesia. [PDF]

J Parasitol Res
Irdayanti I, Aswad H, Asih PBS, Rozi IE, Herdiana H, Diptyanusa A, Prameswari HD, Yusuf Y, Bahrani B, Hidayah N, Artika IM, Syafruddin D.   +11 more
europepmc   +1 more source